Robin Harper Cowie Biodesix Inc (BDSX) insider trading activity

Robin Harper Cowie is CFO, Sec'y & Treasurer of BIODESIX INC. Currently has a direct ownership of 188,969 shares of BDSX, which is worth approximately $298,571. The most recent transaction as insider was on May 23, 2024, when has been sold 13,080 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 189K

11.55% 3M change

61.01% 12M change

Total Value Held $298,571

Robin Harper Cowie Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 23 2024	BUY Exercise of conversion of derivative security	-	13,080 Added 6.47%	188,969 Common Stock
May 21 2024	BUY Exercise of conversion of derivative security	$1,767 $0.42 p/Share	4,209 Added 2.34%	175,889 Common Stock
May 09 2024	SELL Open market or private sale	$1,450 $1.48 p/Share	980 Reduced 0.57%	171,680 Common Stock
May 08 2024	BUY Exercise of conversion of derivative security	-	3,157 Added 1.8%	172,660 Common Stock
Feb 12 2024	SELL Open market or private sale	$14,440 $1.66 p/Share	8,699 Reduced 4.88%	169,410 Common Stock
Feb 09 2024	SELL Open market or private sale	$19,499 $1.92 p/Share	10,156 Reduced 5.39%	178,109 Common Stock
Feb 08 2024	BUY Exercise of conversion of derivative security	-	51,692 Added 21.54%	188,265 Common Stock

Nov 10 2023	SELL Open market or private sale	$603 $1.23 p/Share	491 Reduced 0.36%	136,573 Common Stock
Nov 09 2023	SELL Open market or private sale	$623 $1.27 p/Share	491 Reduced 0.36%	137,064 Common Stock
Nov 08 2023	BUY Exercise of conversion of derivative security	-	3,156 Added 2.24%	137,555 Common Stock
Aug 10 2023	SELL Open market or private sale	$2,270 $1.27 p/Share	1,788 Reduced 1.34%	131,535 Common Stock
Aug 09 2023	SELL Open market or private sale	$2,486 $1.39 p/Share	1,789 Reduced 1.32%	133,323 Common Stock
Aug 08 2023	BUY Exercise of conversion of derivative security	-	11,575 Added 7.89%	135,112 Common Stock
Aug 03 2023	BUY Grant, award, or other acquisition	$9,998 $1.62 p/Share	6,172 Added 4.76%	123,537 Common Stock
May 10 2023	SELL Open market or private sale	$1,537 $1.58 p/Share	973 Reduced 0.82%	117,365 Common Stock
May 09 2023	SELL Open market or private sale	$3,943 $1.57 p/Share	2,512 Reduced 2.08%	118,338 Common Stock
May 08 2023	BUY Exercise of conversion of derivative security	-	11,575 Added 8.74%	120,850 Common Stock
Feb 09 2023	SELL Open market or private sale	$7,596 $1.8 p/Share	4,220 Reduced 4.08%	99,275 Common Stock
Feb 08 2023	BUY Exercise of conversion of derivative security	-	11,575 Added 10.06%	103,495 Common Stock
Nov 21 2022	BUY Grant, award, or other acquisition	$19,999 $1.15 p/Share	17,391 Added 15.91%	91,920 Common Stock
Nov 10 2022	SELL Open market or private sale	$1,614 $1.02 p/Share	1,583 Reduced 2.08%	74,529 Common Stock
Nov 09 2022	SELL Open market or private sale	$2,078 $1.04 p/Share	1,999 Reduced 2.56%	76,112 Common Stock
Nov 08 2022	BUY Exercise of conversion of derivative security	-	11,574 Added 12.91%	78,111 Common Stock
Aug 09 2022	SELL Open market or private sale	$8,938 $2.53 p/Share	3,533 Reduced 5.04%	66,537 Common Stock
Aug 08 2022	BUY Exercise of conversion of derivative security	-	11,575 Added 14.18%	70,070 Common Stock

RHC

Robin Harper Cowie

CFO, Sec'y & Treasurer

Boulder, CO

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BDSX shares.

Notify only if

Value

Insider Trading

Get notified when an Biodesix Inc insider buys or sells BDSX shares.

Notify only if

Operation

Value

Type

News

Receive news related to BIODESIX INC

Track Activities on BDSX

Account